Notes provided by Metriarch unless otherwise noted
One Reply to “HB 3359 (2026)”
HB 3359 amends a requirement that Medicaid cover biomarker testing, making such coverage discretionary even when used for diagnosis, treatment, management, or monitoring and supported by medical evidence.
An Act relating to Medicaid coverage; amending Section 3, Chapter 331, O.S.L. 2023 (56 O.S. Supp. 2025, Section 4003), which relates to biomarker testing coverage; making coverage discretionary; and providing an effective date.
One Reply to “HB 3359 (2026)”
HB 3359 amends a requirement that Medicaid cover biomarker testing, making such coverage discretionary even when used for diagnosis, treatment, management, or monitoring and supported by medical evidence.
Comments are closed.